Alexandria Real Estate Equities Inc (ARE)
Official siteREAL ESTATE • REIT - OFFICE • NYSE
Market Cap: $7.64B
Last updated: Nov 17, 2026 at 11:04 AM ET
Alexandria Real Estate Equities Inc (ARE) Earnings: Report Dates and Results
FFO per share for Alexandria Real Estate Equities (ARE) was $9.00 for 2025. In the quarter ended Sep 30, 2026, Alexandria Real Estate Equities reported EPS of $1.54, above the $1.52 estimate. It beat the EPS estimate in 4 of the 8 most recent quarters that had an estimate. Alexandria Real Estate Equities is expected to report earnings on Jan 25, 2027.
Earnings
Performance (10Y)
Upcoming Estimates
Next Report
ARE has an expected report date of Jan 25, 2027.
ARE Earnings Call
The latest ARE earnings call transcript on file is labeled 2026Q3.
Read the 2026Q3 transcriptEarnings History
Of the 38 quarters below that had an estimate, ARE beat 17 and missed 21. Revenue for the quarter ended Sep 30, 2026 was $671.18M, down 10.7% from $751.94M a year earlier.
| Quarter ended | EPS | Estimate | Range | Surprise | Result | YoY | Analysts | Revisions | Reported | Revenue |
|---|---|---|---|---|---|---|---|---|---|---|
| Sep 30, 2026 | $1.54 | $1.52 | N/A | +1.32% | Beat | +208.0% | 1 | 1 up, 0 down | Oct 26, 2026 | $671.18M |
| Jun 30, 2026 | $1.73 | $1.65 | N/A | +4.85% | Beat | +260.4% | 1 | 0 up, 0 down | Aug 3, 2026 | $662.78M |
| Mar 31, 2026 | $2.10 | $0.14 | $0.04 - $0.28 | N/A | N/A | +311.8% | 5 | 0 up, 0 down | Apr 27, 2026 | $671.02M |
| Dec 31, 2025 | -$6.35 | $0.30 | -$0.56 - $0.50 | N/A | N/A | -1020.3% | 7 | N/A | Jan 26, 2026 | $754.41M |
| Sep 30, 2025 | $0.50 | $0.39 | $0.39 - $0.39 | +28.21% | Beat | -42.5% | 1 | 0 up, 1 down | Oct 27, 2025 | $751.94M |
| Jun 30, 2025 | $0.48 | $0.63 | $0.63 - $0.63 | -23.81% | Miss | -45.5% | 1 | 0 up, 0 down | Jul 21, 2025 | $762.04M |
| Mar 31, 2025 | $0.51 | $0.60 | $0.60 - $0.60 | -15.00% | Miss | -42.7% | 1 | 0 up, 1 down | Apr 28, 2025 | $758.16M |
| Dec 31, 2024 | $0.69 | $0.90 | $0.90 - $0.90 | -23.33% | Miss | -15.9% | 1 | 1 up, 0 down | Jan 27, 2025 | $788.95M |
| Sep 30, 2024 | $0.87 | $0.92 | N/A | -5.43% | Miss | 0.0% | 4 | 0 up, 0 down | Oct 21, 2024 | $791.61M |
| Jun 30, 2024 | $0.88 | $0.61 | $0.61 - $0.91 | +44.26% | Beat | +72.5% | 4 | 0 up, 0 down | Jul 22, 2024 | $766.73M |
| Mar 31, 2024 | $0.89 | $0.63 | $0.63 - $0.87 | +41.27% | Beat | +7.2% | 4 | 0 up, 0 down | Apr 22, 2024 | $769.11M |
| Dec 31, 2023 | $0.82 | $0.80 | $0.29 - $0.86 | +2.50% | Beat | +164.5% | 4 | 0 up, 0 down | Jan 29, 2024 | $757.22M |
| Sep 30, 2023 | $0.87 | $0.88 | $0.78 - $2.07 | -1.14% | Miss | +148.6% | 4 | 0 up, 0 down | Oct 23, 2023 | $713.79M |
| Jun 30, 2023 | $0.51 | $0.39 | $0.02 - $0.89 | +30.77% | Beat | -34.6% | 4 | 0 up, 0 down | Jul 24, 2023 | $713.90M |
| Mar 31, 2023 | $0.83 | $0.79 | $0.55 - $0.97 | +5.06% | Beat | +16.9% | 4 | 0 up, 0 down | Apr 24, 2023 | $700.79M |
| Dec 31, 2022 | $0.31 | $0.74 | N/A | -58.11% | Miss | -46.6% | 1 | 0 up, 0 down | Jan 30, 2023 | $670.28M |
| Sep 30, 2022 | $0.35 | $0.76 | N/A | -53.95% | Miss | -50.0% | 3 | 0 up, 0 down | Oct 24, 2022 | $659.85M |
| Jun 30, 2022 | $0.78 | $0.67 | $0.64 - $0.68 | +16.42% | Beat | +6.8% | 3 | 0 up, 0 down | Jul 25, 2022 | $643.76M |
| Mar 31, 2022 | $0.71 | $0.88 | $0.21 - $1.28 | -19.32% | Miss | -1.4% | 4 | 0 up, 0 down | Apr 25, 2022 | $615.07M |
| Dec 31, 2021 | $0.58 | $0.56 | $0.40 - $1.01 | +3.57% | Beat | -6.5% | 4 | 0 up, 0 down | Jan 31, 2022 | $576.92M |
| Sep 30, 2021 | $0.70 | $0.75 | $0.37 - $0.86 | -6.67% | Miss | +25.0% | 4 | 0 up, 0 down | Oct 25, 2021 | $547.76M |
| Jun 30, 2021 | $0.73 | $0.61 | $0.41 - $0.78 | +19.67% | Beat | +23.7% | 5 | N/A | Jul 26, 2021 | $509.62M |
| Mar 31, 2021 | $0.72 | $0.58 | $0.42 - $0.71 | +24.14% | Beat | +56.5% | 4 | N/A | Apr 26, 2021 | $479.85M |
| Dec 31, 2020 | $0.62 | $0.65 | $0.38 - $0.99 | -4.62% | Miss | -3.1% | 5 | N/A | Feb 1, 2021 | $463.72M |
| Sep 30, 2020 | $0.56 | $0.84 | N/A | -33.33% | Miss | -9.7% | 3 | N/A | Oct 26, 2020 | $545.04M |
| Jun 30, 2020 | $0.59 | $0.54 | $0.30 - $0.76 | +9.26% | Beat | +1.7% | 5 | N/A | Jul 27, 2020 | $436.96M |
| Mar 31, 2020 | $0.46 | $0.74 | $0.50 - $0.74 | -37.84% | Miss | -16.4% | 4 | N/A | Apr 27, 2020 | $439.92M |
| Dec 31, 2019 | $0.64 | $0.61 | $0.43 - $0.72 | +4.92% | Beat | +56.1% | 3 | N/A | Feb 3, 2020 | $408.11M |
| Sep 30, 2019 | $0.62 | $0.20 | $0.20 - $0.80 | +210.00% | Beat | -25.3% | 4 | N/A | Oct 28, 2019 | $390.48M |
| Jun 30, 2019 | $0.58 | $1.00 | N/A | -42.00% | Miss | +28.9% | 3 | N/A | Jul 29, 2019 | $373.86M |
| Mar 31, 2019 | $0.55 | $0.60 | N/A | -8.33% | Miss | +17.0% | 1 | N/A | Apr 29, 2019 | $358.84M |
| Dec 31, 2018 | $0.41 | $0.55 | $0.49 - $0.55 | -25.45% | Miss | -8.9% | 3 | N/A | Feb 4, 2019 | $340.46M |
| Sep 30, 2018 | $0.83 | $0.57 | N/A | +45.61% | Beat | +107.5% | 3 | N/A | Oct 29, 2018 | $341.82M |
| Jun 30, 2018 | $0.45 | $0.55 | $0.49 - $0.64 | -18.18% | Miss | +12.5% | 5 | N/A | Jul 30, 2018 | $325.03M |
| Mar 31, 2018 | $0.47 | $0.51 | $0.48 - $0.54 | -7.84% | Miss | +56.7% | 5 | N/A | Apr 30, 2018 | $320.14M |
| Dec 31, 2017 | $0.45 | $0.40 | $0.37 - $0.42 | +12.50% | Beat | N/A | 5 | N/A | Jan 29, 2018 | $298.79M |
| Sep 30, 2017 | $0.40 | $0.42 | $0.37 - $0.47 | -4.76% | Miss | +90.5% | 5 | N/A | Oct 30, 2017 | $285.37M |
| Jun 30, 2017 | $0.40 | $0.41 | $0.39 - $0.50 | -2.44% | Miss | +2.6% | 4 | N/A | Jul 31, 2017 | $273.06M |
| Mar 31, 2017 | $0.30 | $0.41 | N/A | -26.83% | Miss | -14.3% | N/A | N/A | May 1, 2017 | $270.88M |
| Dec 31, 2016 | -$0.16 | $0.41 | N/A | -139.02% | Miss | -135.6% | N/A | N/A | Jan 30, 2017 | $249.16M |
Annual FFO
FFO per share was $9.00 for 2025, down 0.1% from $9.01 in 2024. It was $5.25 for 2016, the oldest of the 10 years shown.
| Fiscal year | FFO per share | Change |
|---|---|---|
| 2025 | $9.00 | -0.1% |
| 2024 | $9.01 | +7.0% |
| 2023 | $8.42 | +8.5% |
| 2022 | $7.76 | +6.3% |
| 2021 | $7.30 | +4.9% |
| 2020 | $6.96 | +5.5% |
| 2019 | $6.60 | +9.6% |
| 2018 | $6.02 | +9.3% |
| 2017 | $5.51 | +5.0% |
| 2016 | $5.25 | N/A |
Annual EPS
EPS for the fiscal year ended Dec 31, 2025 was -$4.86, after $3.33 the year before. It was $0.79 for the year ended Dec 31, 2016, the oldest of the 10 fiscal years shown.
| Fiscal year ended | EPS | Change |
|---|---|---|
| Dec 31, 2025 | -$4.86 | -245.9% |
| Dec 31, 2024 | $3.33 | +9.9% |
| Dec 31, 2023 | $3.03 | +40.9% |
| Dec 31, 2022 | $2.15 | -21.2% |
| Dec 31, 2021 | $2.73 | +22.4% |
| Dec 31, 2020 | $2.23 | -6.7% |
| Dec 31, 2019 | $2.39 | +10.6% |
| Dec 31, 2018 | $2.16 | +39.4% |
| Dec 31, 2017 | $1.55 | +96.2% |
| Dec 31, 2016 | $0.79 | N/A |
Earnings Calls
The 8 most recent earnings calls are listed below; the latest, 2026Q3 for the period ended Sep 30, 2026, runs about 7,600 words across 15 speakers.
| Call | Period ending | Words | Speakers | Transcript |
|---|---|---|---|---|
| 2026Q3 | Sep 30, 2026 | 7,642 | 15 | |
| 2026Q2 | Jun 30, 2026 | 9,675 | 16 | |
| 2026Q1 | Mar 31, 2026 | 11,011 | 18 | |
| 2025Q4 | Dec 31, 2025 | 8,040 | 17 | |
| 2025Q3 | Sep 30, 2025 | 8,187 | 15 | |
| 2025Q2 | Jun 30, 2025 | 4,929 | 15 | |
| 2025Q1 | Mar 31, 2025 | 6,278 | 15 | |
| 2024Q4 | Dec 31, 2024 | 10,015 | 16 |
2026Q3 Earnings Call
Opening remarks
Paula Schwartz Investor Relations Thank you, and good afternoon, everyone. This conference call contains forward-looking statements within the meaning of the federal securities laws. The company's actual results might differ materially from those projected in the forward-looking statements. Additional information concerning factors that could cause results to differ materially from those in the forward-looking statements is contained in the company's periodic reports filed with the Securities and Exchange Commission. I now would like to turn the call over to Joel Marcus, Executive Chairman and Founder. Please go ahead, Joel.
Joel Marcus Executive Chairman and Founder Thank you, Paula, and good day, everybody, and welcome to Alexandria's third quarter earnings call. First of all, I want to thank each and every member individually and collectively of the Alexandria team for a very solid third quarter 2026. As a family team, we've impacted the lives of countless patients here in the United States and around the world, and thank you for your commitment to the life science sector through real estate venture capital that has really transformed the impact on the growth and success of this amazing industry. And with that, I'd like to highlight a couple of key thoughts before turning it over to Marc Binda, our Chief Financial Officer, to recap the quarter. First of all, under the category of demand and leasing, we had a solid third quarter, leasing over 1.2 million square feet. Notably, we had a weighted average lease term of about 11 years, which is pretty great. And we had the second-highest filling of vacant space in the company's history. Seventy-four percent of our leasing was with existing tenants. We do have the largest life science tenant base in the industry, and it was quite well balanced except for public biotech, but we expect that to contribute importantly to fourth quarter projected leasing of about 1.25 million square feet. Helpful was the defeat of the cap on indirect costs, an issue that we have talked about many times, and the circuit court essentially beating off that cap helped drive institutional demand and leasing this quarter. One interesting indicator: people always wonder about the potential for public biotech health. Rather than the XBI, I think people should look at what's called the BBC ETF, about 129 stocks, 93% of which are clinical stage, which I think reflects the public biotech sector probably more realistically. Clinical-stage biotech valuations still remain well below historical averages. There's been a good contribution this quarter from advanced technology companies, as they're very attracted to our Megacampuses for their recruitment and retention as well as our wonderful infrastructure, which is quite well suited to their businesses.
Frequently Asked Questions About ARE
When is Alexandria Real Estate Equities's next earnings date?
Alexandria Real Estate Equities's next earnings report is expected for Jan 25, 2027.
Did ARE beat earnings estimates last quarter?
Yes. Alexandria Real Estate Equities reported EPS of $1.54 for the quarter ended Sep 30, 2026, above the $1.52 estimate, a 1.32% surprise.
What EPS do analysts expect from ARE next quarter?
The consensus EPS estimate for Alexandria Real Estate Equities for the quarter ending Dec 31, 2026 is -$0.13 from 7 analysts, with estimates from -$0.21 to -$0.06.
How often does ARE beat earnings estimates?
Alexandria Real Estate Equities beat the EPS estimate in 4 of the 8 most recent quarters that had an estimate, with an average surprise of +1.38%.
ARE pages: Overview, Dividends, Earnings, Forecast, Financials, Valuation, Competitors